Cytori to Provide Corporate Update at the 27th Annual ROTH Conference in Laguna Niguel, California
March 06 2015 - 08:00AM
Business Wire
Presentation on March 10, 2015, at 11:00 AM,
Pacific Time
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that
Dr. Marc H. Hedrick, President and CEO of Cytori Therapeutics, will
present at the 27th Annual ROTH Conference in Laguna Niguel,
California, March 8-11, 2015. Cytori’s presentation is scheduled to
begin March 10th at 11:00 AM, Pacific Time, in Track 6, Salon
6.
About the ROTH Conference
The annual ROTH Conference, hosted by Roth Capital Partners, is
one of the largest of its kind with over 500 participating
companies and over 3000 attendees, and features presentations from
hundreds of public and private companies in a variety of
industries, including healthcare. The conference includes company
presentations, one-on-one and small group meetings, and panel
discussions.
About Cytori Therapeutics, Inc.
Cytori Therapeutics is a late stage cell therapy company
developing autologous cell therapies from adipose tissue to treat a
variety of medical conditions. Data from preclinical studies and
clinical trials suggest that Cytori Cell Therapy™ acts principally
by improving blood flow, modulating the immune system, and
facilitating wound repair. As a result, Cytori Cell Therapy™ may
provide benefits across multiple disease states and can be made
available to the physician and patient at the point-of-care through
Cytori’s proprietary technologies and products. For more
information: visit www.cytori.com.
Cytori Therapeutics, Inc.Shawn Richardson,
1-858-875-5279ir@cytori.com
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Mar 2023 to Mar 2024